- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Trans Genic Inc (2342)
The Trans Genic share price today is 256.0, view TYO 2342 stock exchange data. Track the latest Trans Genic share price with real-time updates on 2342 stock performance including market cap, day range, 52-week range and dividend yield. Access 2342 charts, earnings dates and analyst estimates to support your investment decisions.
Tokyo
Currency in JPY
256.0
-3.0(-1.16%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
251.0
260.0
52 wk Range
182.0
487.0
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
251.0260.0
52 wk Range
182.0487.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
2342 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
12-08-2026
EPS / Forecast
8.17 / --
Revenue / Forecast
3.66B / --
Compare 2342 to Peers and Sector
Metrics to compare | 2342 | Sector Sector - Average of metrics from a broad group of related Consumer Cyclicals sector companies | Relationship Relationship2342PeersSector | |
|---|---|---|---|---|
P/E Ratio | −55.4x | −6.4x | −0.4x | |
PEG Ratio | −0.60 | −0.16 | 0.00 | |
Price/Book | 0.9x | 3.1x | 2.6x | |
Price / LTM Sales | 0.3x | 15.2x | 3.1x | |
Upside (Analyst Target) | - | 49.9% | 47.8% | |
Fair Value Upside | Unlock | 13.0% | 6.2% | Unlock |
Transgenic Group Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment and Consulting Business segments. The company provides analysis of the function of individual genes in individuals, elucidation of the relationship between genes and pathology, production of disease model mice, gene expression analysis, and antibody production; clinical trials for pharmaceutical agents, such as bioequivalence studies; administrative services for clinical trials; clinical trials for foods for specified health uses; and hospital support. It also conducts non-clinical studies for pharmaceuticals, medical devices, chemical substances, and food development using small and large animals. In addition, the company offers services related to mergers and acquisitions, business revitalization, business succession, and investment business. The company was formerly known as Trans Genic Inc. and changed its name to Transgenic Group Inc. in October 2024. Transgenic Group Inc. was incorporated in 1998 and is headquartered in Fukuoka City, Japan.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Trans Genic (2342) Share Price Today?
The Trans Genic share price today is 256.0.
What is the current Trans Genic (2342) share price and day range?
As of 15-08-2026, the Trans Genic share price is 256.0, with a previous close of 259.0. The share price has ranged from 251.0 to 260.0 today, while the 52-week range spans from 182.0 to 487.0.
What Is the Trans Genic Market Cap?
As of today, Trans Genic market cap is 4.26B.
What Is Trans Genic's Earnings Per Share (TTM)?
The Trans Genic EPS (TTM) is -4.6.
When Is the Next Trans Genic Earnings Date?
Trans Genic will release its next earnings report on 06-11-2026.
From a Technical Analysis Perspective, Is 2342 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Trans Genic Trade On?
Trans Genic is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Trans Genic?
The stock symbol for Trans Genic is "2342."
How Many Times Has Trans Genic Stock Split?
Trans Genic has split 2 times.
How Many Employees Does Trans Genic Have?
Trans Genic has 227 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.